Clinical Trials Browser

Phase 1/2 × Completed × nintedanib × Clear all

NCT02393755 2021-07-08

Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer

Phase 1/2 Completed

42 enrolled 16 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT02308553 2020-10-14

NIPAWILMA

Phase 1/2 Completed

Melanoma, Cutaneous Malignant